Skip to main content
. 2017 Apr 18;12(4):e0175274. doi: 10.1371/journal.pone.0175274

Fig 2. Diagnostic performance of the 3-protein biomarker panel in discriminating GD patients with moderate-to-severe GO from GD patients without GO.

Fig 2

ROC curve analysis showing LYZ, LACRT and AZGP1 combined in a panel, with an AUC of 0.93. The curve is created by plotting the true positive rate (sensitivity) against the false positive rate (1 –specificity).